#USA #Veeva Systems #Barcelona #Biopharma #RIM

Accelerating Regulatory Processes: The Impact of Veeva RIM

In an era where speed is of the essence, Veeva Systems has revolutionized regulatory information management (RIM) for life sciences companies. With over 450 organizations adopting its platform—including 19 of the 20 largest biopharmaceutical firms—Veeva is streamlining the way these corporations interact with global health authorities.

Transformational Partnerships

Veeva has not only established itself as a leader in regulatory cloud solutions but has also cemented critical partnerships that enhance its service. Recent collaborations with Accumulus Technologies and DNAnexus aim to improve interoperability with the platforms of various health authorities. These innovations are intended to optimize compliance, thereby expediting the drug approval process significantly.

Enhanced Efficiency in Regulatory Teams

According to Marc Gabriel, Vice President of Regulatory at Veeva, teams utilizing their advanced product solutions can continuously improve efficiency and reduce time to market. The seamless integration provides an end-to-end solution that enhances collaboration with stakeholders and facilitates a smooth flow of data, essential in today's fast-paced regulatory landscape.

Streamlining Global Regulatory Processes

Companies leveraging Veeva RIM experience optimized processes throughout all stages of the regulatory lifecycle. Specifically, the Veeva Submissions Publishing functionality allows over 85 companies to utilize continuous publishing, which minimizes revisions, eliminates bottlenecks, and accelerates submission deadlines.

Setting New Standards for Regulatory Collaboration

The strategic alliance with Accumulus Technologies is particularly noteworthy. Francisco Nogueira, CEO of Accumulus, stated that connecting their platform with Veeva RIM would enhance the sharing of information across a growing network of over 70 regulatory agencies worldwide. This will not only improve the interoperability but also significantly reduce delays in bringing important treatments to patients.

Additionally, the integration of DNAnexus Trusted Regulatory Spaces (TRS) with Veeva RIM promises to offer premier data exchange capabilities. This functionality is expected to enhance cross-agency collaboration, leading to quicker regulatory approvals and ultimately facilitating faster patient access to innovative therapies.

The Foundation of Innovative Cloud Solutions

Veeva RIM operates as part of the Veeva Development Cloud, a comprehensive technical foundation for product development covering clinical trials, quality management, regulatory affairs, and safety protocols. This central cloud-based system is designed to streamline compliance processes, ensuring that life sciences companies can navigate the evolving regulatory landscape effectively.

For those who wish to explore the wide array of features Veeva RIM offers, more details can be accessed at veeva.com/eu/RIM.

About Veeva Systems

Veeva Systems stands at the forefront of industry cloud solutions, serving over 1,500 customers including both major biopharmaceutical corporations and emerging biotech firms. With a strong commitment to innovation, product quality, and customer success, Veeva operates as a Public Benefit Corporation, balancing the interests of customers, employees, shareholders, and the industry alike. For more information about Veeva's offerings, visit veeva.com/eu.

Looking Ahead: Future of Regulatory Innovations

The landscape of regulatory science is rapidly transforming, and Veeva's proactive approach to adopting modern technologies ensures that it will remain a key player in this transformation. By continually enhancing its solutions and expanding partnerships, Veeva is setting a new standard for how regulatory information is managed, ultimately improving patient outcomes through faster access to essential therapies.